Sally Ozonoff, Ph.D.

Dr. Ozonoff’s research at the M.I.N.D. Institute focuses on very young children with autism. She is studying the onset of autism in a prospective investigation that follows high-risk infants from birth through age 3. She is also studying risk factors, both biological and behavioral, for autistic regression. Other funded projects include a twin study of autism, an efficacy study of an attention training program for autism, and a study of pragmatic language problems in autism. Dr. Ozonoff’s clinical interests are in the diagnosis, assessment, and treatment of people with autism spectrum disorders, with specializations in infant and adult diagnosis and Asperger syndrome diagnosis and treatment. Dr. Ozonoff has coauthored more than 50 publications, written two books, and contributed many book chapters to her field. She also serves on an NIH study section and the editorial boards of the Journal of Autism and Developmental Disorders, Journal of Child Psychology and Psychiatry, and Development and Psychopathology.